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Purpose: We evaluated the factors that affect the improvement of the initial peak flow rate after transurethral resection of the 
prostate (TURP) or photoselective vaporization of the prostate (PVP) for benign prostatic hyperplasia (BPH) patients by using 
noninvasive tools.
Methods: One hundred and twenty seven BPH patients who had undergone TURP or PVP between January 2005 and May 
2009 were evaluated. They were divided into 2 groups: the postoperative initial peak urinary flow rate (Qmax) was less than 10 
mL/sec (Group 1; n=37, TURP=11, PVP=26) and more than 10 mL/sec (Group 2; n=90, TURP=41, PVP=49). We con-
firmed the patients’ preoperative check lists. The check list were the international prostate symptom score (IPSS), the quality of 
life score, a past history of acute urinary retention (AUR), body mass index and/or pyuria, the serum prostate-specific antigen 
(PSA) level and the prostate volume, the prostate transitional zone volume and prostatic calcification. The initial Qmax was 
measured at the outpatient clinic one week after discharge.
Results: The improvement rate was not significant difference between the TURP group (78.8%) and the PVP group (65.3%). 
The efficacy parameters were the IPSS-storage symptom score, the prostate volume, the PSA level and a past history of AUR. 
The IPSS-storage symptom scores of Group 1 (12.3±3.3) was higher than those of Group 2 (10.5±1.7). The prostate volume of 
Group 2 (42.3±16.6 g) was bigger than that of Group 1 (36.6±7.8 g). The PSA level of Group 2 (3.8±2.6 ng/mL) was higher 
than that of Group 1 (2.6±2.6 ng/mL). A past history of AUR in Group 1 (35.1%) was more prevalent than that of Group 2 
(15.6%). 
Conclusions: The non-invasive factors affecting the initial Qmax after TURP or PVP were the IPSS-storage symptom score, the 
prostate volume and a past history of AUR. Accordingly, in patients who have a higher IPSS-storage symptom score, a smaller 
prostate volume and a history of AUR, there might be a detrimental effect on the initial Qmax after TURP or PVP. These factors 
might also be used as long-term prognostic factors.
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INTRODUCTION
Benign prostatic hyperplasia (BPH) commonly occurs in elder-
ly men, and it is a disease whose prevalence increases with age. 
The treatments for BPH are divided into drug treatment and 
surgical treatment. For the surgical treatment, transurethral re-
section of the prostate (TURP) has been considered as a stan-
dard treatment up to the present [1]. Photoselective vaporiza-
tion of the prostate (PVP) was introduced in the late 1990s and 
many studies have compared it with TURP. As a result, it has 
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been confirmed that these two treatments showed similar ef-
fects and complications [2,3].
  For the case of TURP, the success rate has been reported to 
be 70-90% [4]. Yet in 10-30% of patients, the symptoms are not 
improved following the surgery. Accordingly, several studies 
have been conducted to predict the surgical treatment outcomes. 
As the most objective and reliable test, studies have shown that 
it is important to clarify the degree of the outlet obstruction of 
the bladder by conducting a pressure flow study [5]. In addition, 
a recent study has shown the presence of an overactive bladder 
as well as outlet obstruction of the bladder in many patients 
through a urodynamic study (UDS) [6]. However, a pressure 
flow study and a UDS study are very invasive tests, and so there 
are limitations that both tests cannot be performed for all the 
patients.
  The peak urinary flow rate (Qmax) is the objective indicator 
based on which the postoperative treatment outcomes can be 
evaluated. According to a Korean study where long-term follow 
up was performed for the Qmax, it reached the maximal level 
at the 3rd or 6th postoperative month. As the time elapsed, the 
Qmax showed a slightly decreasing tendency [7]. According to 
another study in which follow-up studies were performed dur-
ing a 7-year postoperative follow-up period, the Qmax was not 
notably continuously decreased after a 1-year postoperative pe-
riod [8]. Based on these findings, it is accepted that the Qmax 
has long-term prognostic value for patients who undergo TURP 
or PVP.
  We conducted this study to identify the factors affecting the 
Qmax in the initial stage after TURP or PVP, based on non-in-
vasive preoperative markers. 
MATERIALS AND METHODS
A total of 275 patients underwent TURP or PVP at our medical 
institution due to BPH during a period ranging from January of 
2005 to May of 2009. The exclusion criteria included patients 
who did not have all their preoperative parameters assessed, 
those who had the concurrent presence of causative diseases 
such as urinary bladder stone, urethral stone and urethral ste-
nosis that caused urinary tract obstruction, those who had pros-
tate cancer that was confirmed postoperatively, those who had 
neurogenic bladder and had a past history of prostate surgery. 
As a result, a total of 127 patients (TURP=52, PVP=72) were 
enrolled in the current study.
  The patients were divided into two groups based on the post-
operative Qmax; we used a cut-off value of 10 mL/sec, which 
implies the presence of outlet obstruction of the urinary blad-
der. The group with a Qmax <10 mL/sec represented a lack of 
the improvement (Group 1; n=37, TURP=11, PVP=26) and 
the groups with a Qmax >10 mL/sec represented some im-
provement (Group 2; n=90, TURP=41, PVP=49). A retro-
spective study was then conducted.
  The preoperative parameters included a prostate-specific an-
tigen (PSA) test, the international prostate symptom score 
(IPSS), a quality of life score (QoL), the Qmax based on uro-
flowmetry, the prostate volume, the transitional zone volume 
(TZV) and the presence of prostatic calcification under the 
guidance of transrectal ultrasonography (TRUS) and the body 
mass index (BMI) based on the height and weight. Of these, the 
IPSS was compared based on storage symptoms (questions 2, 4 
and 7), voiding symptoms (questions 1, 3, 5, and 6) and the to-
tal scores. The TZV was assessed in a total of 127 patients, and 
the TZV measured in only 53 of these patients (TURP=11, 
PVP=42). The presence of calcification was determined in the 
cases in which there was a marked presence of calcified find-
ings with strong echogenicity and a diameter of >3 mm and 
aposterior acoustic shadow regardless of the location of the cal-
cification. The presence of pyuria and a past history of acute 
urinary retention (AUR) were also confirmed. Pyuria was de-
fined as cases in which more than five white blood cells were 
observed on high-magnification light microscopy. All surgeries 
were performed by three surgeons who overcame the learning 
curve. As for the surgical methods, the surgery was done using 
a 24Fr. Wolf resectoscope in the TURP group based on the 
methods that were generally described in a textbook [9]. In the 
PVP group, a potassium-titanyl-phosphate laser with a mean 
output of 80 was used and the surgical procedure was performed 
at a gap of 0.5-1 mm between the laser and the tissue (the near 
contact technique). We performed TRUS guided prostate nee-
dle biopsies in all the patients with an elevated PSA level (≥4 
ng/mL). All the patients postoperatively had a 22Fr. Foley cath-
eter inserted. The catheter was removed on the day of discharge. 
Then, the patients were confirmed to be able to perform self-
voiding. The initial Qmax was measured at the outpatient clinic 
one week after discharge. 
  In the current study, the parameters that showed significance 
for the total population were also separately analyzed in the 
TURP and PVP group. 
  Statistical analysis was performed with Student’s t-test and 
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significant. Statistical analysis was performed using SPSS ver. 
12.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Following the two types of surgery (TURP and PVP), the num-
ber of patients who improved an initial Qmax to >10 mL/sec 
postoperatively was 41 in the TURP group (78.8%) and 49 in 
the PVP group (65.3%). These results indicate that the rate of 
improvement was slightly higher in the TURP group as com-
pared with that of the PVP group, but the difference was not 
statistically significant (P>0.05) (Fig. 1).
  The age was higher in Group 1 (71.3±7.1 years) than that in 
Group 2 (69.3±7.4 years). Preoperatively, the Qmax was higher 
in the Group 2 (8.4±4.5 mL/sec) than that in the Group 1 (7.3 
±5.9 mL/sec), but the differences were not statistically signifi-
cant. The BMI and the presence of pyuria were found to have a 
similar profile in both groups and the differences were not sta-
tistically significant.
  The IPSS-total score, the voiding symptom score and the QoL 
questionnaire showed no significant difference between the two 
groups. But the storage symptom score was found to be 12.3± 
3.3 points in Group 1 and 10.5±1.7 points in Group 2. The 
storage symptom score was significantly lower in Group 2 (Ta-
ble 1).
  In regard to the prostatic factors based on TRUS, there were 
no significant differences of the transitional zone index and 
prostatic calcification between the two groups. However, the 
prostate volume was 36.6±7.8 g in Group 1 and 42.3±16.6 g in 
Group 2. The prostate volume was significantly higher in Group 
2 (Table 1).
  The PSA level was 2.6±2.6 ng/mL in Group 1 and 3.8±2.6 
ng/mL in Group 2. The proportion of patients who had a past 
history of acute urinary retention was found to be 35.1% in 
Group 1 and 15.6 % in Group 2. These results indicate that the 
PSA level was higher and the proportion of patients who had a 
past history of acute urinary retention was lower in Group 2, 
and these differences were statistically significant (Table 1).
  We performed inter-group comparison for the IPSS-storage 
score, the prostate volume, the PSA level and a past history of 
AUR, which were all found to be statistically significance in all 
the patient groups and it showed that the prostate volume (37.2 
±7.7 g vs. 48.3±20.0 g) showed a significant difference in the 
TURP group (Table 2). In the PVP group, the IPSS storage score 
(12.5±3.1 points vs. 10.8±1.8 points) and the PSA level (1.9± 
2.1 ng/mL vs. 3.4±2.3 ng/mL) were found to be significantly 
different. (Table 3). 
Table 1. Perioperative characteristics and perioperative date 
Patient
P-value
Group 1 (n=37) Group 2 (n=90)
Age (yr) 71.3±7.1 69.3±7.4 0.160
Qmax (mL/sec)
 a) 7.3±5.9 8.4±4.5 0.257
IPSS-storage  12.3±3.3 10.5±1.7 0.003
 b)
IPSS-voiding  12.0±5.2 13.4±4.3 0.128
IPSS-total  24.4±6.3 23.9±5.1 0.677
QoL 4.3±0.8 4.3±1.0 0.983
Prostate volume (g) 36.6±7.8 42.3±16.6 0.009
 b)
TZV (g) (n=53) 16.9±9.8 23.9±13.6 0.138
TZI (%) (n=53) 44.6±18.2 49.9±10.0 0.315
PSA (ng/mL) 2.6±2.6 3.8±2.6 0.037
 b)
BMI 24.3±3.3 24.5±3.0 0.716
AUR 35.1 15.6 0.014
 b)
Prostatic calcification 32.4 26.7 0.512
Pyuria 16.2 15.6 0.926
Values are presented as mean±SD or %.
Group 1, initial Qmax <10 mL/sec; Group 2, initial Qmax ≥10 mL/
sec; Qmax, peak urinary flow rate; IPSS, international prostate symp-
tom score; QoL, quality of life; TZV, transitional zone volume; TZI, 
transitional zone index; PSA, prostate specific antigen; BMI, body mass 
index; AUR, acute urinary retention. 
a)Preoperative Qmax. 
b)P<0.05.
Fig. 1. Improvement rate of postoperative peak urinary flow 
rate in both group. Qmax, peak urinary flow rate; TURP, trans-
urethral resection of the prostate; PVP, photoselective vaporiza-
tion of the prostate.
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DISCUSSION
To date, several studies have been conducted to predict the treat-
ment outcomes of TURP, which is routinely performed in pa-
tients with BPH. Yet in regard to PVP, it is difficult to identify 
the treatment outcomes. In the current study, a retrospective 
analysis was performed by considering the two treatment mo-
dalities as a single modality based on several recent reports 
showing that the treatment outcomes are similar between PVP 
and TURP [2,3]. 
  In the recent studies that focused on the prognostic factors of 
the treatment outcomes of TURP, it was important to evaluate 
the degree of the outlet obstruction of the bladder by using UDS 
or a pressure flow study. These studies were conducted using 
objective data. Yet it is true that a UDS or a pressure flow study 
cannot be performed for all the patients because of the studies’ 
invasiveness. Accordingly, in the current study, a UDS and a 
pressure flow study were not performed. Instead, based on the 
preoperative characteristics of the patients that were found us-
ing such non-invasive methods as TRUS, a lab study and physi-
cal examination, we attempted to examine the factors affecting 
the Qmax in the early phase of the postoperative stage.
  In regard to the prostate volume, many controversial opin-
ions exist regarding its correlation with the voiding symptoms 
of patients. Jensen et al. [10] reported that the degree of the im-
provement of symptoms is not affected by the prostate volume 
following surgery. According to Cockett et al. [11] on the pre-
operative work-up of patients with BPH, as the prostate volume 
was greater, the postoperative outcomes were better. Also in our 
study, the prostate volume was 42.3±16.6 g in Group 2 and 
36.6±7.8 g in Group 1. There was a discrepancy by approxi-
mately 5.7 g on average. In association with this, as the prostate 
volume was relatively greater, there was a higher possibility for 
the occurrence of outlet obstruction of the bladder. This might 
be similar to the reports by Jung et al. [6] that the treatment 
outcomes were more satisfactory following TURP in the group 
where there was outlet obstruction of the bladder as compared 
with the treatment outcomes of the group without outlet ob-
struction of the bladder. 
  IPSS is a fundamental tool by which the lower urinary tract 
symptoms can be quantitatively measured. Hakenberg et al. [12] 
examined the changes in the IPSS prior to and following TURP 
based on a classification into a storage symptom score and a 
voiding symptom score. As a result, the storage symptom score 
was decreased by 3.4 points and the voiding symptom score 
was decreased by 6.2 points. Based on these results, the decre-
mental degree of the voiding symptom score was relatively low-
er than that of the storage symptom score.
  Im et al. [13] reported that the satisfactory of TURP outcome 
decreased when storage symptom score was superior to voiding 
symptom score. Also in our study, it was confirmed that the 
mean preoperative storage symptom score was higher by 1.8 
points in Group 1, in which the symptoms were not improved. 
These results indicate that the IPSS storage symptom score is an 
indicator that should be evaluated prior to TURP or PVP.
  AUR is one of the serious complications that occur following 
the onset of BPH. It may occur due to such factors as excessive 
water drinking, alcohol intake, an anti-histamine intake and the 
aggravation of the systemic status. According to Chang et al. 
[14] the age, the prostate volume, the transition zone volume 
and its index (TZI) can be used as prognostic indicators. Yet to 
date, no studies have examined whether a past history of AUR 
Table 2. Comparisons of factors that showed significance in the 
total population at TURP group
Patient
P-value
Group 1 (n=11) Group 2 (n=41)
IPSS-storage  11.9±3.8 10.0±1.4 0.151
Prostate volume (g) 37.2±7.7 48.3±20.0 0.007
 a)
PSA (ng/mL) 4.6±3.0 4.2±2.8 0.722
AUR  36.4 14.6 0.104
Values are presented as mean±SD or %.
TURP, transurethral resection of the prostate; Group 1, initial Qmax 
<10 mL/sec; Group 2, initial Qmax ≥10 mL/sec; IPSS, international 
prostate symptom score; PSA, prostate specific antigen; AUR, acute 
urinary retention.
a)P<0.05.
Table 3. Comparisons of factors that showed significance in the 
total population at PVP group
Patient
P-value
Group 1 (n=26) Group 2 (n=49)
IPSS-storage  12.5±3.1 10.8±1.8 0.019
 a)
Prostate volume (g) 36.3±7.9 37.2±10.6 0.675
PSA 1.9±2.1 3.4±2.3 0.007
 b)
AUR  34.6 16.3 0.072
Values are presented as mean±SD or %.
PVP, photoselective vaporization of the prostate; Group 1, initial Qmax 
<10 mL/sec; Group 2, initial Qmax ≥10 mL/sec; IPSS, international 
prostate symptom score; PSA, prostate specific antigen; AUR, acute 
urinary retention.
a)P<0.05. 
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can affect the improvement of symptoms that occur following 
TURP or PVP. In the current study, the proportion of patients 
with a past history of AUR was 15.6% in Group 2. This was low-
er than 35.1% in Group 1, in which the symptoms were not im-
proved following TURP or PVP. Jang et al. [15] reported that 
the detrusor muscle was overstretched and its contractility was 
reduced in patients with chronic urinary retention. Those au-
thors noted that the voiding functions might be difficult in these 
patients despite prostatectomy. The accurate reasons for this 
cannot be clarified. It is assumed that there is a higher possibili-
ty for the progression to chronic urinary retention in patients 
with a past history of AUR because there is a higher degree of 
sensitivity to the factors that aggravate the AUR. Thus, it is as-
sumed that an assessment of the status of the urinary bladder 
would be essential with the use of a UDS and cystoscopy prior 
to performing TURP or PVP in patients with BPH and who 
have a past history of AUR.
  In the current study, the PSA level was interpreted to be a 
significant factor affecting the improvement of symptoms. Ac-
cording to a Korean study where the correlation between the 
prostate volume and PSA was assessed, Cho et al. [16] reported 
that the prostate volume was correlated with the PSA level in a 
logarithmical manner. Those authors also noted that the rate of 
an increased prostate volume was relatively higher as time 
elapsed. In the current study, a comparison was made for age 
and the PSA level between the two groups. Then the results 
were also compared with those reported by Cho et al. [16]. This 
showed the similar results, based on which it is assumed that 
the PSA level is not a factor affecting the initial Qmax, but it 
should be considered to be the difference in PSA level due to 
that in the prostate volume between the two groups. According 
to a study that examined the factors affecting the improvement 
of symptoms following TURP, Kim et al. [17] reported that the 
improvement of symptoms was decreased in cases in which 
calcification was present in the central region of the prostate 
gland. According to Lee et al. [18] satisfactory surgical out-
comes could be expected in cases in which the TZI was rela-
tively higher as compared with those case with a lower TZI. In 
the current study, both calcification of the prostate and the TZI 
seemed to be statistically insignificant for the initial Qmax after 
TURP or PVP. Based on these findings, the presence of calcifi-
cation was solely confirmed without confirming the location of 
calcification in the cases with calcification of the prostate. How-
ever, for the cases with TZI, the number of patients for which 
the TZI was measured at our medical institution was relatively 
smaller than the previous studies, and this might be one of the 
limitations of the current study.
  In the current study, the factors affecting the Qmax in the 
initial stage following TURP or PVP were found to include the 
IPSS-storage symptom score, the prostate volume, the PSA level 
and a past history of AUR. When these factors were confirmed 
in both the TURP group and the PVP group, it was found that 
the prostate volume was a significant factor in the TURP group, 
and the IPSS-storage symptom score and PSA level were signif-
icant factors in the PVP group. However, these results might 
have come about from the fact that TURP was frequently per-
formed in the patients with a greater volume of the prostate as 
compared to the PVP group and the number of total number of 
subject patients was relatively small. So, this finding cannot be 
generalized, which is also one of the limitations of the current 
study. Further large-scale studies are warranted to examine the 
factors affecting TURP and PVP, and studies with long-term 
follow-up are also needed.
  The current study is not devoid of other limitations. TURP 
and PVP showed similar result, but they are different proce-
dures. So, the idea that they have same preoperative factors af-
fecting treatment result has a burden.  Procedures were per-
formed three surgeons and this study didn’t consider the resect-
ed volume of prostate in TURP. However, despite these biases, 
we think that this study can be helpful in predicting the result 
of BPH surgery preoperatively.
  In conclusion, following TURP or PVP, which are both com-
monly performed to surgically treat patients with BPH, the non-
invasive factors affecting the initial Qmax include the IPSS-stor-
age symptom score, the prostate volume and a past history of 
AUR. Accordingly, in patients who have a higher IPSS-storage 
symptom score, a smaller prostate volume and a past history of 
AUR, there might be a detrimental effect on the improvement 
of the Qmax in the initial stage following the surgery. These fac-
tors might also be used as long-term prognostic factors for pa-
tients who undergo TURP or PVP. 
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